Loading...
I-1-deficiency negatively impacts survival in a cardiomyopathy mouse model
AIMS: Hypertrophic cardiomyopathy (HCM) is characterized by left ventricular hypertrophy, diastolic dysfunction and increased interstitial fibrosis. Current treatment is based on beta-adrenoceptor (AR) and calcium channel blockers. Since mice deficient of protein phosphatase-1 inhibitor-1 (I-1), an...
Na minha lista:
| Udgivet i: | Int J Cardiol Heart Vasc |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5497269/ https://ncbi.nlm.nih.gov/pubmed/28785686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2015.05.010 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|